Researchers find targeted therapy combination overcomes treatment resistance in liver cancer
April 13, 2008Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients.
Liver cancer is resistant to many chemotherapies and to cell-death inducing agents. Last year, however, the U.S. Food and Drug Administration approved sorafenib (Nexavar®) as a treatment for liver cancer after a clinical trial showed that the targeted agent prolonged survival in some patients.
Unfortunately not all patients respond to sorafenib and the drug does not cure the disease.
Therefore, Wafik El-Deiry, MD, PhD, Professor of Medicine, Genetics, and Pharmacology, and co-Program Leader of Radiation Biology in the Abramson Cancer Center, and colleagues have tested other targeted agents in combination with sorafenib.
They found that treating liver cancer cells with sorafenib and an antibody or the natural ligand that stimulates programmed cell death via the TRAIL pathway, dramatically increases the rate of cell death.
“Sorafenib by itself causes a little cell death, but not that much,” Dr. El-Deiry said. “Now you combine sorafenib and TRAIL, and all of the sudden you get massive cell death. It is a real synergistic interaction. It is very profound killing.”
The combination works regardless of whether the researchers use a monoclonal antibody that stimulates the TRAIL receptor, which resides on the surface of the cancer cells, or the receptor’s natural ligand, a small protein called TRAIL. Both the antibody and the TRAIL ligand are currently being tested as single agents in patients.
Within the next several months, Dr. El-Deiry’s team expects to announce the details for a trial testing the combination in patients.
In a healthy individual, the immune system uses the TRAIL pathway to rid the body of unwanted cells, including precancerous ones. Once cancer develops, however, the cells often become less responsive to TRAIL activation, in part because of an overabundance of a protein called Mcl-1, according to Dr. El-Deiry. His team found that sorafenib reduces the amount of Mcl-1 in the cancer cells, restoring their sensitivity to TRAIL-induced cell death.
Although the Penn investigators focused their current report on liver cancer, they discovered that the sorafenib-TRAIL combination also kills colon cancer cell in vitro and in animal models.
Source: University of Pennsylvania
-
Possible new pathway can overcome glioblastoma resistance
Jan 24, 2012 |
5 / 5 (1) |
0
-
Sensing the deep ocean
Dec 20, 2011 |
5 / 5 (1) |
0
-
Mushroom compound appears to improve effectiveness of cancer drugs
Oct 11, 2011 |
5 / 5 (2) |
0
-
Cancer stem cell discovery
Sep 15, 2011 |
not rated yet |
0
-
Doctors question Perry's stem cell back treatment
Aug 19, 2011 |
3 / 5 (2) |
25
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Researchers make breakthrough in stem cell research
(Medical Xpress) -- University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.
20 minutes ago |
5 / 5 (1) |
0
|
Georgia Tech develops software for the rapid analysis of foodborne pathogens
2011 brought two of the deadliest bacterial outbreaks the world has seen during the last 25 years. The two epidemics accounted for more than 4,200 cases of infectious disease and 80 deaths. Software developed at Georgia Tech ...
12 minutes ago |
not rated yet |
0
Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you
(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...
Medicine & Health / Psychology & Psychiatry
42 minutes ago |
4 / 5 (1) |
0
Couples in the same place emotionally stay together, study says
(Medical Xpress) -- Despite lifes ups and downs, couples whose feelings are in sync consistently over time are more likely to stay together, says a University of California, Davis, study.
Medicine & Health / Psychology & Psychiatry
7 minutes ago |
not rated yet |
0
|
Low levels of amplitude-modulated electromagnetic fields elicit therapeutic responses cancer patients
Ryne Ramaker, a senior UALR Donaghey Scholar and University Science Scholar with a double major in biology and chemistry, is a co-author of a cancer research paper creating excitement among other researchers. The article ...
29 minutes ago |
not rated yet |
0
New molecule has potential to help treat genetic diseases and HIV
(PhysOrg.com) -- Chemists at The University of Texas at Austin have created a molecule that's so good at tangling itself inside the double helix of a DNA sequence that it can stay there for up to 16 days before ...
With climate change, today's '100-year floods' may happen every three to 20 years: research
Last August, Hurricane Irene spun through the Caribbean and parts of the eastern United States, leaving widespread wreckage in its wake. The Category 3 storm whipped up water levels, generating storm surges ...
The joy of cheques
An electronic cheque which eliminates the need for costly processing by banks but preserves the simplicity and ease of a traditional cheque book has been designed by a team of academics in the UK.
Research shows promise in converting camelina oil into jet fuel
(PhysOrg.com) -- Researchers at Montana State University-Northern have developed a process to convert camelina oil to jet fuel and other high-value chemicals. MSU has applied for a U.S. patent and research is ongoing.
Omega-3 fatty acid on trial: Study to evaluate long-term effects on intelligence, behavior
University of Kansas researchers John Colombo and Susan Carlson have been awarded $2.5 million for the next five years of a 10-year, double-blind randomized controlled trial to determine whether prenatal nutritional supplementation ...
Research finds injuries to professional athletes from routine play or practice often reported as 'freak accidents' in me
(Medical Xpress) -- A new report from the Johns Hopkins Center for Injury Research and Policy finds injuries to professional athletes from routine play or practice are often characterized as freak accidents in ...